Aimei Health Technology Co., Ltd (AFJK)
NASDAQ: AFJK · Real-Time Price · USD
11.00
0.00 (0.00%)
Mar 24, 2025, 4:00 PM EST - Market closed
Company Description
Aimei Health Technology Co., Ltd does not have significant operations.
It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities.
It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.
Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
Aimei Health Technology Co., Ltd
| Country | United States |
| Founded | 2023 |
| IPO Date | Dec 4, 2023 |
| Industry | Shell Companies |
| Sector | Financials |
| CEO | Junheng Xie |
Contact Details
Address: 10 East 53rd Street, Suite 3001 New York, New York 10022 United States | |
| Phone | 212 845 9945 |
Stock Details
| Ticker Symbol | AFJK |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $10.00 |
| CIK Code | 0001979005 |
| ISIN Number | KYG013411098 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Junheng Xie | Chief Executive Officer, Secretary and Director |
| Heung Ming Wong | Chief Financial Officer and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 7, 2025 | SCHEDULE 13G/A | Filing |
| Mar 7, 2025 | SCHEDULE 13G/A | Filing |
| Mar 6, 2025 | 8-K | Current Report |
| Feb 14, 2025 | SCHEDULE 13G | Filing |
| Feb 14, 2025 | SCHEDULE 13G | Filing |
| Feb 13, 2025 | SCHEDULE 13G/A | Filing |
| Feb 13, 2025 | SCHEDULE 13G | Filing |
| Feb 7, 2025 | 8-K | Current Report |
| Feb 4, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Feb 4, 2025 | 8-K | Current Report |